SYNERGISTIC EFFECT OF 4-HYDROPEROXYCYCLOPHOSPHAMIDE (4-HC) AND CISPLATIN (CP) FOR EXVIVO BONE-MARROW PURGING

被引：0
|
作者：
PETERS, RH [1 ]
STUART, RK [1 ]
机构：
[1] MED UNIV S CAROLINA,CHARLESTON,SC 29425
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1987年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：415 / 415
页数：1
相关论文
共 50 条
  • [21] Autologous bone marrow transplantation (ABMT) with 4-hydroperoxycyclophosphamide (4HC) purging as treatment for indolent non-Hodgkins lymphoma (NHL).
    Marcellus, DC
    Abrams, RA
    Seifter, EJ
    Diguiseppe, J
    Mann, RB
    Piantadosi, S
    Miller, CB
    Gore, SD
    Jones, RJ
    Ambinder, RF
    BLOOD, 1998, 92 (10) : 463A - 463A
  • [22] USE OF LONG-TERM HUMAN MARROW CULTURES TO DEMONSTRATE PROGENITOR-CELL PRECURSORS IN 4-HYDROPEROXYCYCLOPHOSPHAMIDE (4-HC) TREATED MARROW
    WINTON, EF
    COLENDA, KW
    EXPERIMENTAL HEMATOLOGY, 1985, 13 (05) : 343 - 343
  • [23] MULTIPHASE THERAPY OF MULTIPLE-MYELOMA (MM) USING HIGH-DOSE BUSULFAN, MELPHALAN AND CYCLOPHOSPHAMIDE (BU+MEL+CY) FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION (AUBMT) WITH 4-HYDROPEROXYCYCLOPHOSPHAMIDE (4-HC) PURGING
    REECE, DE
    NANTEL, SH
    SUTHERLAND, HJ
    KLINGEMANN, HG
    BARNETT, MJ
    SHEPHERD, JD
    PHILLIPS, GL
    BLOOD, 1993, 82 (10) : A266 - A266
  • [24] BONE-MARROW MICROMETASTASES IN CHEMOTHERAPY-RESPONSIVE ADVANCED BREAST-CANCER - EFFECT OF EX-VIVO PURGING WITH 4-HYDROPEROXYCYCLOPHOSPHAMIDE
    PASSOSCOELHO, J
    ROSS, AA
    DAVIS, JM
    HUELSKAMP, AM
    CLARKE, B
    NOGA, SJ
    DAVIDSON, NE
    KENNEDY, MJ
    CANCER RESEARCH, 1994, 54 (09) : 2366 - 2371
  • [25] EFFECTS OF INVITRO PURGING WITH 4-HYDROPEROXYCYCLOPHOSPHAMIDE ON THE HEMATOPOIETIC AND MICROENVIRONMENTAL ELEMENTS OF HUMAN-BONE MARROW
    SIENA, S
    CASTROMALASPINA, H
    GULATI, SC
    LU, L
    COLVIN, MO
    CLARKSON, BD
    OREILLY, RJ
    MOORE, MAS
    BLOOD, 1985, 65 (03) : 655 - 662
  • [26] USE OF LONG-TERM BONE-MARROW CULTURES TO DEMONSTRATE THE PROTECTION OF HUMAN STEM-CELLS BY IL-1 AND TNF-ALPHA FROM 4-HYDROPEROXYCYCLOPHOSPHAMIDE (4-HC)
    ZUCALI, JR
    MOREB, J
    BAIN, C
    LYMPHOKINE RESEARCH, 1990, 9 (04): : 610 - 610
  • [27] MARROW PURGING IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA - EFFICACY OF EXVIVO TREATMENT WITH IMMUNOTOXINS AND 4-HYDROPEROXYCYCLOPHOSPHAMIDE AGAINST FRESH LEUKEMIC MARROW PROGENITOR CELLS
    UCKUN, FM
    GAJLPECZALSKA, K
    MEYERS, DE
    RAMSAY, NC
    KERSEY, JH
    COLVIN, M
    VALLERA, DA
    BLOOD, 1987, 69 (01) : 361 - 366
  • [28] DETECTION OF RESIDUAL MURINE LPC-1 MYELOMA CELLS FROM BONE-MARROW CELL MIXTURE AFTER PURGING BY 4-HYDROPEROXYCYCLOPHOSPHAMIDE
    FRONDOZA, CG
    SINHA, S
    TRIVEDI, SM
    HUMPHREY, RL
    COLVIN, OM
    EXPERIMENTAL HEMATOLOGY, 1987, 15 (06) : 715 - 718
  • [29] AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA USING 4-HYDROPEROXYCYCLOPHOSPHAMIDE AND VP-16 PURGED BONE-MARROW
    GULATI, S
    ACABA, L
    YAHALOM, J
    REICH, L
    MOTZER, R
    CROWN, J
    DOHERTY, M
    CLARKSON, B
    BERMAN, E
    ATZPODIEN, J
    ANDREEFF, M
    GEE, T
    BONE MARROW TRANSPLANTATION, 1992, 10 (02) : 129 - 134
  • [30] Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purging produces durable remissions in patients with follicular lymphoma.
    Flinn, IW
    Jones, RJ
    Garrett, E
    Miller, CB
    Gore, SD
    Smith, G
    Ambinder, RF
    BLOOD, 2003, 102 (11) : 735A - 735A
12345